CraigYoshitsuguOkadaMD
Hematology • Portland, ORAssistant Professor, Medicine, Oregon Health and Science University School of Medicine
Are you Dr. Okada?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-6594
Summary
- Dr. Craig Okada, MD is a hematologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Michigan, and California. He is affiliated with OHSU Hospital and Portland HCS.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1993 - 1996- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1990 - 1993
Stanford University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - Present
OR State Medical License 2004 - 2025
MI State Medical License 1998 - 2005- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma Start of enrollment: 2008 May 01
- Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma.Riyad N H Seervai, Craig Y Okada, Stephanie J Mengden-Koon, Noah I Hornick
JAAD Case Reports. 2024-11-01 - 6 citationsEpcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan
The Lancet. Haematology. 2024-08-01 - Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu
Clinical Cancer Research. 2023-10-13
Professional Memberships
- Member
